Onyx Pharmaceuticals, Inc.

354 articles about Onyx Pharmaceuticals, Inc.

• 

  Three Biopharma Companies Bolster Leadership Teams

  2/23/2022

  Silence Therapeutics, Totus Medicines and Poseida Therapeutics all adjust as they welcome new members to their leadership teams.

• Tarveda Therapeutics Appoints Jeffrey Bloss, M.D. as Chief Medical Officer

  9/12/2018

  Steven Hamburger, Ph.D. appointed as Vice President, Regulatory Affairs and Laura Mei appointed as Vice President, Clinical Operations.

• Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer

  8/16/2018

  Synthorx, Inc. today announced the appointment of Joseph Leveque, M.D., as chief medical officer.

• Gamida Cell Expands Leadership Team with Appointments of Tzvi Palash as Chief Operating Officer and John Schick as Vice President of Market Access

  7/23/2018

  Gamida Cell today announced the appointments of Tzvi Palash as chief operating officer (COO) and John D. Schick as vice president, market access.

• 

  A Look at 6—Count ‘em, 6!—Biotech IPOs This Week

  6/21/2018

  It’s a super-busy week for biotech initial public offerings (IPOs) with six companies raking in a total of around $568 million.

• Onyx Helps Accelerate TopiVert’s Compounds To Clinic

  7/21/2017

• Google's Verily Employees Make Themselves at Home at Onyx's Former HQ

  3/24/2017

• A Look at Amgen and Its $10 Billion Flop Onyx

  11/3/2016

• Google's Verily to Lease Onyx's Old Space in South San Francisco, Campus Can House Up to 1,000

  2/19/2016

• Embattled Theranos, Layoffs at Onyx And Other Events Shaped the Bay Area Biotech Community in 2015

  1/4/2016

• PRC Clinical To Host Expert Panel On “The Road To Econsent” At Onyx

  10/21/2015

• MPM Capital Appoints Pablo J. Cagnoni, M.D., Former OnyxPresident, As Managing Director And CEO Of MPM Immunotherapy Portfolio Company Vesuvius.

  5/21/2015

• MPM Capital Appoints Pablo J. Cagnoni, M.D., Former Onyx President, As Managing Director And CEO Of MPM Immunotherapy Portfolio Company Vesuvius.

  5/20/2015

• Amgen Will Shutter SSF Onyx Site, Lay Off At Least 300

  3/16/2015

• Fate Unknown for Remaining 200 Onyx Employees; Will They Head to Washington State?

  3/13/2015

• The Reason Why Onyx's Experiment To Become The Next Genentech Failed

  3/12/2015

• Medtronic Initiates Pivotal Studies Of Resolute Onyx Drug-Eluting Stent In United States

  3/12/2015

• Why Ex-Onyx CEO And Big Pharma Are Taking On Brain Diseases

  2/13/2015

• Ex-Onyx Pharmaceuticals, Inc. CEO Leads MA Biotech Startup

  12/16/2014

• Amgen And Onyx Pharmaceuticals, Inc. Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma

  12/8/2014